Innovative Eyewear (LUCY) Competitors $5.72 +0.14 (+2.51%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LUCY vs. LUCD, BLAC, CTSO, ICAD, MODD, NTRB, STIM, CLGN, MDAI, and SURGShould you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include Lucid Diagnostics (LUCD), Bellevue Life Sciences Acquisition (BLAC), Cytosorbents (CTSO), iCAD (ICAD), Modular Medical (MODD), Nutriband (NTRB), Neuronetics (STIM), CollPlant Biotechnologies (CLGN), Spectral AI (MDAI), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. Innovative Eyewear vs. Lucid Diagnostics Bellevue Life Sciences Acquisition Cytosorbents iCAD Modular Medical Nutriband Neuronetics CollPlant Biotechnologies Spectral AI SurgePays Lucid Diagnostics (NASDAQ:LUCD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, community ranking, institutional ownership, valuation, risk, analyst recommendations and earnings. Do analysts rate LUCD or LUCY? Lucid Diagnostics currently has a consensus price target of $3.63, indicating a potential upside of 374.29%. Innovative Eyewear has a consensus price target of $20.00, indicating a potential upside of 249.65%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Lucid Diagnostics is more favorable than Innovative Eyewear.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is LUCD or LUCY more profitable? Innovative Eyewear has a net margin of -514.01% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat Innovative Eyewear's return on equity.Company Net Margins Return on Equity Return on Assets Lucid Diagnostics-1,069.87% N/A -123.54% Innovative Eyewear -514.01%-115.86%-105.40% Which has better valuation & earnings, LUCD or LUCY? Innovative Eyewear has lower revenue, but higher earnings than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLucid Diagnostics$4.19M10.83-$52.67M-$1.14-0.67Innovative Eyewear$1.56M8.95-$6.66M-$9.66-0.59 Which has more risk and volatility, LUCD or LUCY? Lucid Diagnostics has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.52, meaning that its stock price is 152% more volatile than the S&P 500. Does the MarketBeat Community prefer LUCD or LUCY? Lucid Diagnostics received 34 more outperform votes than Innovative Eyewear when rated by MarketBeat users. However, 100.00% of users gave Innovative Eyewear an outperform vote while only 67.92% of users gave Lucid Diagnostics an outperform vote. CompanyUnderperformOutperformLucid DiagnosticsOutperform Votes3667.92% Underperform Votes1732.08% Innovative EyewearOutperform Votes2100.00% Underperform VotesNo Votes Do institutionals and insiders believe in LUCD or LUCY? 74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 8.8% of Lucid Diagnostics shares are owned by insiders. Comparatively, 6.4% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to LUCD or LUCY? In the previous week, Lucid Diagnostics had 3 more articles in the media than Innovative Eyewear. MarketBeat recorded 4 mentions for Lucid Diagnostics and 1 mentions for Innovative Eyewear. Lucid Diagnostics' average media sentiment score of 0.44 beat Innovative Eyewear's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lucid Diagnostics 0 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryLucid Diagnostics beats Innovative Eyewear on 13 of the 19 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Innovative Eyewear News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCY vs. The Competition Export to ExcelMetricInnovative EyewearOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.97M$11.16B$5.24B$9.28BDividend YieldN/A0.97%5.12%4.28%P/E Ratio-0.5941.3787.5417.25Price / Sales8.954.481,164.33121.12Price / CashN/A16.6943.3837.82Price / Book0.663.364.844.94Net Income-$6.66M$235.23M$121.05M$225.76M7 Day Performance-3.05%-0.51%2.49%3.92%1 Month Performance-16.86%-8.72%17.57%1.71%1 Year Performance-34.10%-0.76%28.57%15.79% Innovative Eyewear Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCYInnovative Eyewear1.3132 of 5 stars$5.72+2.5%$20.00+249.7%-34.3%$13.97M$1.56M-0.599Gap UpLUCDLucid Diagnostics2.8007 of 5 stars$0.78-0.4%$3.63+366.2%-45.4%$46.14M$4.19M-0.6870Gap UpBLACBellevue Life Sciences AcquisitionN/A$11.27+0.1%N/A+7.6%$45.54MN/A0.00N/ANews CoverageCTSOCytosorbents2.51 of 5 stars$0.83-9.3%$2.00+141.0%-49.3%$45.38M$33.79M-2.31186Gap UpHigh Trading VolumeICADiCAD0.1225 of 5 stars$1.70-7.1%N/A+4.7%$45.12M$18.94M-13.0867MODDModular Medical3.249 of 5 stars$1.27-8.6%$5.00+293.7%-22.8%$44.06MN/A-2.0239NTRBNutriband0.4319 of 5 stars$3.90-4.4%N/A+31.9%$43.31M$2.02M-5.4910STIMNeuronetics3.0959 of 5 stars$1.33-4.3%$4.67+250.9%-45.5%$40.36M$72.71M-1.08180News CoverageCLGNCollPlant Biotechnologies3.1702 of 5 stars$3.38-0.9%$12.50+269.8%-32.2%$38.72M$650,000.00-2.1970Gap UpHigh Trading VolumeMDAISpectral AI2.4285 of 5 stars$2.08+10.1%$4.50+116.3%-18.8%$38.66M$27.26M-3.2078Gap UpSURGSurgePays2.2855 of 5 stars$1.76-0.6%$8.50+382.9%-68.9%$35.49M$83.60M-1.5622Gap Up Related Companies and Tools Related Companies LUCD Competitors BLAC Competitors CTSO Competitors ICAD Competitors MODD Competitors NTRB Competitors STIM Competitors CLGN Competitors MDAI Competitors SURG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LUCY) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredThe Key to Feeding 8.1 Billion PeopleImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovative Eyewear, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovative Eyewear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
